-
The National Cholesterol Education Program, a product of a collaboration of the National Heart, Lung, and Blood Institutes, the American College of Cardiology, and the American Heart Association, has updated its clinical practice guideline on cholesterol management.
-
-
The hundreds of presentations at this meeting provided encouraging evidence that existing Alzheimers therapies may have greater benefits than first realized, and that a new generation of potential disease-modifying therapies for AD may be on the way.
-
It seems prudent to strongly consider use of melatonin in our cognitively delayed patients with disordered sleep, but to monitor those with epilepsy very closely for exacerbation, and withdraw the drug.
-
These studies provide additional data about the higher risk of relapse, and the greater potential for progression of disability following childbirth.
-
Absence of evidence-based medicine is both humbling, as well as a reminder of how substantial a role the art and oral tradition of medicine plays in the care of neurologic patients.
-
Methylprednisolone significantly improves the recovery of peripheral vestibular function in patients with vestibular neuritis, whereas valacyclovir does not.
-
-
A recent ruling by the Arizona Court of Appeals may mean that workers hurt on the job who test positive for illegal substances cant be denied workers compensation benefits in that state. An attorney familiar with the case says other states may or may not face similar challenges.
-
An easy-to-use on-line tool can help employers get an idea of the time and money lost due to depression among employees.
